A Consensus Statement for Safety Monitoring Guidelines of Treatments for Major Depressive Disorder

Abstract

ObjectiveThis paper aims to present an overview of screening and safety considerations for the treatment of clinical depressive disorders and make recommendations for safety monitoring.MethodData were sourced by a literature search using MEDLINE and a manual search of scientific journals to identify relevant articles. Draft guidelines were prepared and serially revised in an iterative manner until all co-authors gave final approval of content.ResultsScreening and monitoring can detect medical causes of depression. Specific adverse effects associated with antidepressant treatments may be reduced or identified earlier by baseline screening and agent-specific monitoring after commencing treatment.ConclusionThe adoption of safety monitoring guidelines when treating clinical depression is likely to improve overall physical health status and treatment outcome. It is important to implement these guidelines in the routine management of clinical depression.

Defining "elderly" in clinical practice guidelines for pharmacotherapy

“…32 “With sulphonylureas special care needs to be taken, especially in the elderly, not to precipitate hypoglycaemia”. 33 “Starting dose for pregablin is 75 mg bd (25-50 mg in the elderly and frail) [ 34 ] “Care should always be taken with opioid doses in the elderly and in the use of morphine in patients with renal failure” [ 35 ] “More caution (with tricyclic antidepressants) is indicated in children and the elderly and at higher doses” [ 36 ] …”

The Integrative Management of Treatment-Resistant Depression: A Comprehensive Review and Perspectives

“…The reader is referred to other sources for a more detailed discussion on the monitoring of other iatrogenic effects (e.g. weight gain and metabolic complications) throughout antidepressant treatment [166]. …”

Addressing Suicide Risk in Emergency Department Patients

“…3 There are 130 million patient visits to emergency departments each year, so there is much room for improvement. 4 There are 27 000 board-certified emergency physicians in the United States, so calling for enhanced training is a start but is unlikely, by itself, to result in substantive improvement in the management of suicidal patients. Good evidence-based research is also needed to answer vexing questions.…”

“…Although emergency departments provide important opportunities for linking patients to community mental health services, there are limitations to performing thorough diagnostic evaluations to exclude medical and self-limiting factors, assessing potential risks and benefits of antidepressants, selecting optimal treatments for individual patients, and initiating plans for monitoring treatment safety and effectiveness in an emergency department setting. 4 The latency in antidepressant response also argues in favor of initiating antidepressant treatment within the context of an ongoing clinical relationship rather than an emergency department visit. In the Sequenced Treatment Alternatives to Relieve Depression study, only half of the patients with depression who eventually remitted did so during the first 6 weeks of treatment.…”

“…Others have reported similarly low concordance between platforms 3 and analytic pipelines. 4 Uncertainty in variant interpretation remains a significant challenge in clinical genomic sequencing, even for patients with syndromic phenotypes, 5,6 and is not unique to our experience. The variability in reported diagnostic yield that Grody and colleagues describe is at least partially reflective of this uncertainty.…”